Bioventus Inc. (BVS): Cost of Revenue
$179.93M
Year ended 2025-12-31
$182.40M
Trailing 12 months to 2026-06-27
-0.2%
3-year compound annual growth
+15.5%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $179.93M | -2.8% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $185.05M | +0.5% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | $184.15M | +1.7% | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | $181.04M | +41.2% | 2025-03-11, From 2022-01-01 |
| 2021-12-31 | $128.19M | +46.3% | 2024-03-12, From 2021-01-01 |
| 2020-12-31 | $87.64M | -3.6% | 2023-03-31, From 2020-01-01 |
| 2019-12-31 | $90.94M | n/a | 2022-03-11, From 2019-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Bioventus Inc. (BVS) | 2025-12-31 | $179.93M | -2.8% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $432.39M | +20.9% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $133.75M | +13.6% |
| Glaukos Corp (GKOS) | 2025-12-31 | $111.81M | +18.9% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $166.88M | +21.6% |
| Artivion, Inc. (AORT) | 2025-12-31 | $157.10M | +12.4% |
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $219.89M | +19.3% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $232.27M | +24.0% |
| Mimedx Group, Inc. (MDXG) | 2025-12-31 | $73.01M | +21.5% |
Compare BVS, UFPT, ATRC, GKOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗